Evidence map›Paper›PMID 42006055›Full record

ReviewFrontiers in psychiatry2026

The neurobiological synergy of transcranial magnetic stimulation and mindfulness-based interventions in treatment-resistant depression: a narrative review.

Sonora Yun, Martijn Figee

Abstract readReview
In one paragraph

Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sonora YunThe Department of Psychiatry, The Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Martijn FigeeThe Department of Psychiatry, The Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment-resistant depression (TRD) poses a significant challenge, with many patients failing to achieve remission with conventional therapies. While repetitive Transcranial Magnetic Stimulation (rTMS) is an established and effective neuromodulatory treatment for TRD, a notable proportion of patients do not fully respond. Despite the clinical utility of rTMS, response variability remains a significant barrier to treatment optimization. We propose that this variability may be driven, in part, by fluctuations in baseline network configuration and momentary brain states. This motivates the investigation of behavioral state manipulation as a means to prime neural circuits for enhanced receptivity to neuromodulation. This mini-review proposes that combining TMS with adjunctive, short-duration mental practices, specifically Mindfulness Based Interventions (MBI), may enhance therapeutic outcomes. Given that both TMS and mindfulness converge on modulating brain networks regulating emotions, attention and self-referential processes, it is plausible that their concurrent or sequential use could yield additive or even synergistic effects on network reorganization. We will explore the theoretical neurobiological mechanisms that may support a potential synergistic or additive effect and synthesize the limited but promising evidence from analogous therapeutic combinations to argue for the clinical viability of this novel approach. This review aims to: (1) Summarize the shared network targets (DMN, CEN, and SN) of rTMS and mindfulness; (2) Propose a state-dependent synergy model for their integration; and (3) Synthesize existing evidence to guide future clinical trial design.

Indexed as

CENcentral executive networkdefault mode networkDMNMBImindfulness based interventionsrTMSsalience network

Identifiers

PMID42006055
PMCPMC13083115

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.